Esophageal Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Esophageal Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-06-29Clinical Trial Update: Tislelizumab With Chemotherapy or Radiation for Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma (TINES) [Phase 4]
Phase 4 trial evaluating tislelizumab with chemotherapy or radiation as neoadjuvant therapy for esophageal squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2023-05-18Clinical Trial Update: Anlotinib Combined With TQB2450 (PD-L1 Inhibitor) in the Treatment of Advanced Esophageal Squamous Cell Carcinoma(ESCC) [Phase 2]
Phase 2 trial evaluating the combination of anlotinib with PD-L1 inhibitor TQB2450 in advanced esophageal squamous cell carcinoma is ongoing…
-
CLINICAL_TRIALS trial_result · 2023-04-19Clinical Trial Update: To Evaluate the Efficacy and Safety of Afatinib for Advanced ALTRK-negative ESCC [Phase 2]
Phase 2 trial update evaluating afatinib for efficacy and safety in advanced ALTRK-negative esophageal squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: A Clinical Trial Comparing HLX10 With Placebo Combined With Chemotherapy (Cisplatin + 5-fu) in the First-line Treatment of Locally Advanced/Metastatic Esophageal Squamous Cell Carcinoma (ESCC) [Phase 3]
Phase 3 trial comparing HLX10 with placebo plus chemotherapy in first-line locally advanced or metastatic esophageal squamous cell carcinoma…
-
CLINICAL_TRIALS trial_result · 2023-04-10Clinical Trial Update: Pembrolizumab Plus Paclitaxel, Cisplatin Followed by Surgery for Locally Advanced ESCC (KEYSTONE-001) [Phase 2]
Phase 2 trial exploring pembrolizumab with paclitaxel and cisplatin followed by surgery for locally advanced esophageal squamous cell carcin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-03-21Clinical Trial Update: Z650 in Advanced Esophageal Squamous Cell Carcinoma With EGFR Over Expression or Gene Amplification [Phase 1, Phase 2]
Clinical trial update for Z650 in advanced esophageal squamous cell carcinoma with EGFR overexpression or gene amplification completed phase…
-
CLINICAL_TRIALS trial_result · 2023-03-14Clinical Trial Update: Tislelizumab Combined With Neoadjuvant Radiotherapy and Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma. [Phase 2]
Phase 2 clinical trial exploring tislelizumab with neoadjuvant radiotherapy and chemotherapy for resectable esophageal squamous cell carcino…
-
CLINICAL_TRIALS trial_result · 2023-03-06Clinical Trial Update: Tucidinostat Plus PD-1 Inhibitor and Bevacizumab for Advanced Esophagus Cancer, AEG, Gastric Cancer [Phase 2]
Phase 2 trial investigating tucidinostat with a PD-1 inhibitor and bevacizumab in advanced esophageal and gastric cancers; status is current…
-
CLINICAL_TRIALS trial_result · 2023-02-17Clinical Trial Update: Efficacy and Safety of TPF Induction Chemotherapy for Borderline-resectable Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial update on induction chemotherapy (TPF) for borderline-resectable esophageal squamous cell carcinoma, reporting efficacy and sa…
-
CLINICAL_TRIALS trial_result · 2023-02-17Clinical Trial Update: Study of Icotinib Hydrochloride in Treating Patients With Recurrent or Metastatic Esophageal Cancer After Failure of Conventional Chemotherapy [Phase 2]
Phase 2 trial evaluating icotinib hydrochloride in recurrent or metastatic esophageal squamous cell carcinoma after failure of conventional …
-
CLINICAL_TRIALS trial_result · 2023-02-16Clinical Trial Update: Apatinib for Esophageal Squamous Cell Cancer After the Failure of Standard Treatment [Phase 2]
Phase 2 trial updating apatinib for esophageal squamous cell carcinoma after standard-treatment failure has completed.
-
CLINICAL_TRIALS trial_result · 2023-02-16Clinical Trial Update: Endostar Combined With Paclitaxel and Nedaplatin in Treating Patients With Recurrent or Metastatic Esophageal Cancer [Phase 2]
Phase 2 clinical trial evaluating Endostar in combination with Paclitaxel and Nedaplatin for recurrent or metastatic esophageal cancer has c…
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Chemoradiotherapy of Capecitabine With or Without Oxaliplatin Versus Cisplatin-5-FU for Esophageal Squamous Cancer [Phase 3]
Phase 3 trial comparing capecitabine with or without oxaliplatin to cisplatin-5-FU for esophageal squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2023-01-11Clinical Trial Update: Percutaneous Endoscopic Gastrostomy Before Definitive Concurrent Chemoradiation Therapy for Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial update evaluating percutaneous endoscopic gastrostomy before definitive concurrent chemoradiation in esophageal squamous cell …
-
CLINICAL_TRIALS trial_result · 2022-12-14Clinical Trial Update: Camrelizumab Combined With Neoadjuvant Concurrent Chemoradiotherapy for Resectable Locally Advanced ESCC（NICE-RT） [Phase 2]
Phase 2 trial evaluating camrelizumab with neoadjuvant concurrent chemoradiotherapy for resectable locally advanced esophageal squamous cell…
-
CLINICAL_TRIALS trial_result · 2022-12-06Clinical Trial Update: Low Dose Decitabine in Combination With Tirelizumab Comparison of Tirelizumab in the First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial update evaluating low dose decitabine with tirelizumab versus tirelizumab alone as first-line treatment for advanced esophagea…
-
CLINICAL_TRIALS trial_result · 2022-12-05Clinical Trial Update: A Phase II Clinical Study of Fruquintinib Combined With S-1 for Advanced Esophageal Squamous Cell Carcinoma [Phase 2]
Phase II clinical trial evaluating Fruquintinib in combination with S-1 for advanced esophageal squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2022-12-05Clinical Trial Update: Carrelizumab Combined With Chemotherapy for Adjuvant Therapy of Esophageal Squamous Cell Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating carrelizumab in combination with chemotherapy as adjuvant therapy for Esophageal squamous cell carcinoma…
-
CLINICAL_TRIALS trial_result · 2022-11-28Clinical Trial Update: Pembrolizumab and Photodynamic Therapy in Previously Treated Metastatic Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial evaluating pembrolizumab combined with photodynamic therapy in previously treated metastatic esophageal squamous cell carcinom…
-
CLINICAL_TRIALS trial_result · 2022-11-28Clinical Trial Update: Patient-reported Outcomes in Preoperative Immunochemotherapy/Radiotherapy-treated Esophageal Cancer Patients [Phase 2]
Phase 2 trial update evaluating patient-reported outcomes in preoperative immunochemotherapy/radiotherapy-treated esophageal cancer patients…
-
CLINICAL_TRIALS trial_result · 2022-10-26Clinical Trial Update: Moderately Hypofractionated Conformal Radiation Combined With S-1 for Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial evaluating moderately hypofractionated conformal radiation with S-1 for esophageal squamous cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2022-10-26Clinical Trial Update: AK104 Plus Concurrent Chemoradiation Therapy in Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial update for AK104 combined with concurrent chemoradiation in esophageal squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2022-10-25Clinical Trial Update: Sintilimab Plus NCT or NCRT Versus NCRT for ESCC [Phase 3]
Phase 3 trial comparing Sintilimab plus NCT or NCRT versus NCRT for Esophageal Squamous Cell Carcinoma is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2022-10-05Clinical Trial Update: Neoadjuvant Chemotherapy Versus Surgery Alone for Esophageal Squamous Cell Carcinoma [Phase 3]
Phase 3 trial comparing neoadjuvant chemotherapy to surgery alone for esophageal squamous cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2022-09-29Clinical Trial Update: A Multicenter Open-label Phase II Trial to Evaluate Nivolumab and Ipilimumab for 2nd Line Therapy in Elderly Patients With Advanced Esophageal Squamous Cell Cancer [Phase 2]
A multicenter open-label Phase II trial evaluated nivolumab plus ipilimumab as second-line therapy in elderly patients with advanced esophag…